Early Aggressive Enteral Feeding in Neonates Weighing 750-1250 Grams: A Randomized Controlled Trial

Manoj Modi1, Siddarth Ramji2, Ashish Jain2

  • 1Department of Pediatrics, Maulana Azad medical college, New Delhi, India. Correspondence to: Dr Manoj Modi, Department of Neonatology, Sir Ganga Ram hospital, New Delhi, India. drmanojmodi@gmail.com.

Indian Pediatrics
|May 9, 2019
PubMed

Insights

Aggressive enteral feeding in preterm neonates (750-1250 g) is feasible and leads to earlier full feeds. However, it did not significantly reduce mortality or major morbidities compared to conservative feeding.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Clinical Research

Background:

  • Enteral feeding in preterm neonates is advanced slowly due to necrotizing enterocolitis risk.
  • Prolonged intravenous alimentation increases sepsis risk in neonates, especially in low-resource settings.

Purpose of the Study:

  • To evaluate the impact of aggressive enteral feeding on mortality and morbidities in preterm neonates.
  • Assessing the feasibility and outcomes of early aggressive feeding strategies.

Main Methods:

  • Randomized controlled trial involving 131 preterm neonates (birth weight 750-1250 g).
  • Comparison between aggressive and conservative enteral feeding regimens.
  • Primary outcome: all-cause mortality; secondary outcomes: sepsis, necrotizing enterocolitis, feed intolerance, survival without major morbidity, time to full enteral feed, hospitalization duration, and weight gain.

Main Results:

  • All-cause mortality was 33.3% with aggressive feeding vs. 43.1% with conservative feeding (not statistically significant).
  • Aggressive feeding led to earlier achievement of full enteral feeds (median 7 days vs. 10 days, P <0.001).
  • No significant differences were observed in culture-proven sepsis, necrotizing enterocolitis, feed intolerance, or survival without major morbidities.

Conclusions:

  • Early aggressive enteral feeding is feasible in preterm neonates (750-1250 g).
  • This approach did not significantly reduce all-cause mortality, sepsis, or major morbidities.
  • Aggressive feeding reduced time on IV fluids and accelerated time to full enteral feeds.
Abstract

Related Concept Videos

Aggression01:47

Aggression

Humans engage in aggression when they seek to cause harm or pain to another person. Aggression takes two forms depending on one’s motives: hostile or instrumental. Hostile aggression is motivated by feelings of anger with intent to cause pain; a fight in a bar with a stranger is an example of hostile aggression. In contrast, instrumental aggression is motivated by achieving a goal and does not necessarily involve intent to cause pain (Berkowitz, 1993); a contract killer who murders for...
30.1K
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
1.4K
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
920
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
403